
Aaryan Panchal
CEO · FounderLeads strategy and operations. Owns the path from prototype to FDA submission and brings the team together around a single, uncompromising mission: get epinephrine into pockets.
We sit across strategy, operations, design, and research. Each of us owns one slice of the path from prototype to pharmacy shelf.

Leads strategy and operations. Owns the path from prototype to FDA submission and brings the team together around a single, uncompromising mission: get epinephrine into pockets.

Runs day-to-day operations and partnerships. Has spent the last nine months turning the engineering pipeline, regulatory roadmap, and supply chain from spreadsheets into a working plan.

Owns industrial design and the digital product. Responsible for every line, curve, and pixel that makes EpiSafe feel less like a medical device and more like something you actually want to carry.

Leads product research by gathering user feedback, identifying safety risks, and making sure EpiSafe solves a real, validated need.
Business, regulatory, and venture advisors who keep us honest on the path from prototype to FDA submission.
Advises on company strategy, fundraising, and go-to-market as EpiSafe moves from concept to a fundable medical-device company.
LinkedIn →Brings FDA and regulatory experience to the combination-product strategy , predicate selection and the road to a 510(k) pre-submission.
LinkedIn →Our WPI i3 Lab advisor , mentoring the team through the accelerator and opening doors across the medical-device and investor network.
LinkedIn →As we move from prototype to FDA pre-submission, we're hiring across mechanical, regulatory, software, and operations.
Owns the next mechanism revision: spring force, fluid path, and the cartridge geometry that has to survive every drop and every degree.
Drives the 510(k) submission end-to-end: predicate selection, performance testing protocol, and the Q-Sub meeting with FDA.
Ships the companion app and the firmware that talks to it. Owns Bluetooth LE, device state, and the moments first responders will rely on.
Stands up the manufacturing partner relationship, the BOM, and the path from pilot tooling to volume production.
We're early. The work is unglamorous before it's important. If you've shipped hardware or software inside a regulated company, or you've lived with the carrying problem yourself, we want to hear from you.
Investors, advisors, allergy-community folks, and curious engineers, all welcome.